[Table 2](#pone.0204463.t001){ref-type="table"}, "IPA Pathways Associated With IL13Rα2 Expression in Patient Tumor Samples, IL13Rα2-positive Cell Lines, and Mesenchymal Signature Genes," incorrectly appears as a duplicate of Table 1. The figure caption appears correctly. Please see the corrected [Table 2](#pone.0204463.t001){ref-type="table"} here.
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###### IPA Pathways Associated with IL13Rα2 Expression in Patient Tumor Samples, IL13Rα2-positive Cell Lines, and Mesenchymal Signature Genes.
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  Rank   IL13Rα2-positive Cell Lines[\*](#t001fn001){ref-type="table-fn"}^,^[^1^](#t001fn002){ref-type="table-fn"}   IL13Rα2 Over-expressing Patient Tumors[\*](#t001fn001){ref-type="table-fn"}^,^[^2^](#t001fn003){ref-type="table-fn"}   Mesenchymal Signature Genes[\*](#t001fn001){ref-type="table-fn"}^,^[^3^](#t001fn004){ref-type="table-fn"}
  ------ ----------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------
  1      NRF2-mediated Oxidative Stress Response                                                                     **Antigen Presentation Pathway**                                                                                       **Hepatic Fibrosis / Hepatic Stellate Cell Activation**
  2      **Hepatic Fibrosis / Hepatic Stellate Cell Activation**                                                     Cell Cycle Control of Chromosomal Replication                                                                          **TREM1 Signaling**
  3      Caveolar-mediated Endocytosis Signaling                                                                     **Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells**                                                          **Dendritic Cell Maturation**
  4      **Antigen Presentation Pathway**                                                                            Protein Ubiquitination Pathway                                                                                         **IL-6 Signaling**
  5      p38 MAPK Signaling                                                                                          Cdc42 Signaling                                                                                                        HMGB1 Signaling
  6      **Communication between Innate and Adaptive Immune Cells**                                                  **Hepatic Fibrosis / Hepatic Stellate Cell Activation**                                                                **IL-10 Signaling**
  7      Death Receptor Signaling                                                                                    **TREM1 Signaling**                                                                                                    Coagulation System
  8      **TREM1 Signaling**                                                                                         Atherosclerosis Signaling                                                                                              NF-κB Signaling

\*FDR \< 0.05; Immune function-related pathways are indicated in bold and shading.

^1^IPA pathways associated with differential gene expression between IL13Rα2-positive and IL13Rα2-negative cell lines (\|fold-change\| \> 1.5; FDR \<0.05).

^2^IPA pathways associated with differential gene expression for patient samples, defined as genes positively correlated with IL13Rα2 in at least 4 independent cohorts.

^3^IPA pathways associated with canonical mesenchymal signature genes defined by Verhaak et al. \[5\]. Note that Hepatic Fibrosis and TREM1 signaling are among the top 8 enriched pathways for all 3 gene lists.
